Study: Drug sales may not benefit from ads directed to patients

USA Today, September 2, 2008
Spending on direct-to-consumer advertising of prescription drugs continues to rise, but a new study suggests it might not be worth the cost. Drug companies spent an estimated $4.24 billion on direct-to-consumer ads in 2005, more than triple what they spent in 1996. But it was still far less than what they spend on marketing to doctors, researchers report.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.